Temporary Use Authorization News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Temporary Use Authorization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Temporary Use Authorization Today - Breaking & Trending Today

ABIONYX Pharma Announces Its Cash Position and Provides an Activity Update for the 3rd Quarter 2021

Published: November 4, 2021

Regulatory News: ABIONYX Pharma (FR0012616852 ABNX PEA PME eligible) (Paris:ABNX) a next-generation biotech company dedicated to the discovery and development of innovative therapies, announces

Source: finanznachrichten.de

Eiger BioPharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update

Published: November 4, 2021

/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...

Source: prnewswire.com

ABIONYX Pharma Initiates Discussions With IRIS Pharma, a World Leader in Preclinical and Clinical Ophthalmology Research, With a View to a Possible Strategic Deal

Published: October 11, 2021

Regulatory News: ABIONYX Pharma (Paris:ABNX) (FR0012616852 ABNX PEA PME eligible), a next-generation biotech company dedicated to the discovery and development of innovative therapies, announced

Source: finanznachrichten.de

ABIONYX Pharma Announces Positive Preclinical Results in a Model of Uveitis and Launches the Strategic Development of the First Class of Biomedicines in Ophthalmology Based on its bio-HDL

Published: October 7, 2021

Positive preclinical results in a model of uveitis Development of the first class of biomedicines in ophthalmology with bio-HDL Regulatory News: ABIONYX Pharma (Paris:ABNX) (FR0012616852

Source: finanznachrichten.de